John Talian, is Senior Vice President, Regulatory Affairs at Curevac.  He is a senior regulatory affairs leader with over 25 years’ experience in the development, registration and life cycle management of compounds in the global marketplace.  He has interacted extensively with FDA, EMA, and other health authorities worldwide.

Before joining Curevac, he led the Regulatory Affairs group at Hurley Consulting, was Vice President, US Head of Regulatory Affairs, Global Regulatory Affairs at Bayer Healthcare Pharmaceuticals where he led a staff of 80 professionals with both local and global responsibilities for development projects and marketed products, as well as compliance activities.  He managed critical US regulatory activities for the Bayer portfolio of products.  He previously worked for Hoffmann-LaRoche Pharmaceuticals, Inc., in various regulatory positions in the US and Swiss Headquarters.  Dr. Talian holds both a bachelor’s degree in cell and molecular biology and a doctoral degree in cell biology.